利托那韦

pro_cas
162990-01-4 ;155213-67-5
pro_cdbregno
CCD00180242
pro_formula
C37 H48 N6 O5 S2
pro_molWeight
720.955

basic_info

Product_Name: 利托那韦
CAS: 162990-01-4 ;155213-67-5
中文同义词: 利托那韦
EnglishSynonyms: THIAZOL-5-YLMETHYL (2S,3S,5S)-3-HYDROXY-5-((S)-2-(3-((2-ISOPROPYLTHIAZOL-4-YL)METHYL)-3-METHYLUREIDO)-3-METHYLBUTANAMIDO)-1,6-DIPHENYLHEXAN-2-YLCARBAMATE ; NORVIR SOFTGEL ; RTV ; 1,3-THIAZOL-5-YLMETHYL N-[(2S,3S,5S)-3-HYDROXY-5-[(2S)-3-METHYL-2-([METHYL(([2-(PROPAN-2-YL)-1,3-THIAZOL-4-YL]METHYL))CARBAMOYL]AMINO)BUTANAMIDO]-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE ; 1,3-THIAZOL-5-YLMETHYL N-[(2S,3S,5S)-3-HYDROXY-5-[[(2S)-3-METHYL-2-[[METHYL-[(2-PROPAN-2-YL-1,3-THIAZOL-4-YL)METHYL]CARBAMOYL]AMINO]BUTANOYL]AMINO]-1,6-DIPHENYLHEXAN-2-YL]CARBAMATE ; ABT 538 ; RITONAVIR ; 1,3-THIAZOL-5-YLMETHYL N-[(2S,3S,5R)-3-HYDROXY-5-[[(2S)-3-METHYL-2-[[METHYL-[(2-PROPAN-2-YL-1,3-THIAZOL-4-YL)METHYL]CARBAMOYL]AMINO]BUTANOYL]AMINO]-1,6-DIPHENYL-HEXAN-2-YL]CARBAMATE ; (3S,4S,6S,9S)-4-HYDROXY-12-METHYL-9-(1-METHYLETHYL)-13-[2-(1-METHYLETHYL)-4-THIAZOLYL]-8,11-DIOXO-3,6-BIS(PHENYLMETHYL)-2,7,10,12-TETRAAZATRIDECANOIC ACID 5-THIAZOLYLMETHYL ESTER ; NORVIR ; ((1S,2S,4S)-1-BENZYL-2-HYDROXY-4-((S)-2-[3-(2-ISOPROPYL-THIAZOL-4-YLMETHYL)-3-METHYL-UREIDO]-3-METHYL-BUTYRYLAMINO)-5-PHENYL-PENTYL)-CARBAMIC ACID THIAZOL-5-YLMETHYL ESTER
pro_mdlNumber: MFCD00927142
pro_acceptors: 11
pro_donors: 4
pro_smile: CC(C)c1nc(cs1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2ccccc2)C[C@@H]([C@H](Cc3ccccc3)NC(=O)OCc4cncs4)O
InChi: InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1
InChiKey: InChIKey=NCDNCNXCDXHOMX-XGKFQTDJSA-N

property

Comments: GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA
OTHER NOTES: SALES RESTRICTIONS MAY APPLY

secure_info

* If the product has intellectual property rights, a license granted is must or contact us.